Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract

European Journal of Cancer

Volumn 35, Issue 10, 1999, Pages 1541-1545

  Plouzek, C A ^a,c   Ciolino, H P ^b   Clarke, R ^b   Yeh, G G ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c Amer Inst of Biological Services   (United States)

Author keywords

Breast cancer; Doxorubicin; Multidrug resistance; P glycoprotein; Rosemary

Indexed keywords

AZIDOPINE; DOXORUBICIN; GLYCOPROTEIN P; ROSMARINUS OFFICINALIS EXTRACT; VINBLASTINE;

ARTICLE; BREAST CANCER; CELL LINE; CONTROLLED STUDY; DRUG ACCUMULATION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LAMIACEAE; P-GLYCOPROTEINS; PLANT EXTRACTS;

EID: 0032828093     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00180-X     Document Type: Article

References (19)

1. Lehnen M. Chemotherapy resistance in breast cancer. Anti-cancer Res 1998, 18, 2225-2226.
2. Gottesman MM, Pastan I, Ambudkar SV. P-glycoprotein and multidrug resistance. Curr Opin Genet Dev 1996, 6, 610-617.
3. Sarkadi B, Muller M. Search for specific inhibitors of multidrug resistance in cancer. Semin Cancer Biol 1997, 8, 171-182.
4. Bellamy WT, Dalton WS, Dorr RT. The clinical relevance of multidrug resistance. Cancer Invest 1990, 8, 547-562.
5. Atadja P, Watanabe T, Xu H, Cohen D. PSC-833, a frontier in modulation of P-glycoprotein mediated multidrug resistance. Cancer Metastasis Rev 1998, 17, 163-168.
6. Phang JM, Poore CM, Lopaczynska J, Yeh GC. Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrugresistant breast cancer cells. Cancer Res 1993, 15, 5977-5981.
7. Critchfield JW, Welsh CJ, Phang JM, Yeh GC. Modulation of Adr accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem Pharmacol 1994, 48, 1437-1445.
8. Singletary K, MacDonald C, Wallig M. Inhibition by rosemary and carnosol of 7, 12-dimethylbenz [a] anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation. Cancer Lett 1996, 104, 43-48.
9. Huang MT, Ho CT, Wang ZY, et al. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 1994, 54, 701-708.
10. Minnunni M, Wolleb U, Mueller O, Pfeifer A, Aeschbacher HU. Natural antioxidants as inhibitors of oxygen species induced mutagenicity. Mutât Res 1992, 269, 193-200.
11. Santamaria L, Tateo T, Bianchi A, Bianchi L. Rosmarinus officinalis extract inhibits as antioxidant mutagenesis by 8-methoxypsoralen (8-MOP) and benzo[a]pyrene (BP) in Salmonella typhurium. Med Biol Environ 1987, 15, 97-101.
12. Lemonica IP, Damasceno DC, di-Stasi LC. Study of the embryotoxic effects of an extract of rosemary (Rosmarinus officinalis L.). Braz J Med Biol Res 1996, 29, 223-227.
13. Wu JW, Lee MH, Ho CT, Chang SS. Elucidation of the chemical structures of natural antioxidants isolated from rosemary. J Am Oil Chem Soc 1982, 59, 339-345.
14. Yeh GC, Lopaczynska J, Poore CM, Phang JM. A new functional role for P-glycoprotein: efflux pump for benzo(alpha)pyrene in human breast cancer MCF-7 cells. Cancer Res 1992, 52, 6692-6695.
15. Clarke R, Currier S, Kaplan O, et al. Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells. J Natl Cancer Inst 1992, 84, 1506-1512.
16. Rubinstein LV, Shoemaker RH, Paull KD, et al. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst 1990, 82, 1113-1118.
17. Chang SS, Ostric-Matijasevic B, Hsieh OA, Huang CL. Natural antioxidants from rosemary and sage. J Food Sci 1977, 42, 1102-1106.
18. Schoenlein PV. Role of gene amplification in drug resistance. In Goldstein LJ, Ozols RF, eds. Anticancer Drug Resistance: Advances in Molecular and Clinical Research. Boston, Massachussetts, Kluwer Academic Publishers, 1994, 167-200.
19. Deely RG, Cole SP. Function, evolution and structure of multidrug resistance protein (MRP). Semin Cancer Biol 1997, 8, 193-204.